Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 4,180 | 2,010 | 17,890 | 2,320 |
| Marketable Securities | 740 | 33,690 | 1,170 | 52,630 |
| Receivables | 700 | 260 | 870 | 0 |
| Other current assets | 17,340 | 10 | 33,270 | 1,380 |
| TOTAL | $22,960 | $35,970 | $53,200 | $56,330 |
| Non-Current Assets | ||||
| PPE Net | 3,140 | 3,470 | 2,850 | N/A |
| Investments And Advances | 670 | 0 | 0 | 0 |
| Other Non-Current Assets | 150 | 130 | 0 | 10,450 |
| TOTAL | $3,960 | $3,600 | $2,850 | $10,450 |
| Total Assets | $24,850 | $37,880 | $54,780 | $67,870 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,000 | 2,570 | 1,160 | 2,580 |
| Other current liabilities | 1,240 | 0 | 1,460 | 0 |
| TOTAL | $4,240 | $2,570 | $2,620 | $2,580 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 470 | 200 | 700 |
| TOTAL | $N/A | $470 | $200 | $700 |
| Total Liabilities | $4,240 | $3,050 | $2,830 | $3,290 |
| Shareholders' Equity | ||||
| Common Shares | 590 | 590 | 0 | 580 |
| Retained earnings | -69,300 | -55,010 | -37,870 | -24,860 |
| Other shareholders' equity | 10 | -50 | -50 | 20 |
| TOTAL | $20,600 | $34,830 | $51,950 | $64,580 |
| Total Liabilities And Equity | $24,840 | $37,880 | $54,780 | $67,870 |